2021
DOI: 10.1016/j.suronc.2021.101578
|View full text |Cite
|
Sign up to set email alerts
|

Advanced image analytics predicting clinical outcomes in patients with colorectal liver metastases: A systematic review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 48 publications
0
5
0
Order By: Relevance
“…There are, however, some studies that did not incorporate validation into their models, such as [ 12 , 16 ]. In addition, studies produced contradictory results that were difficult to compare [ 41 ]. To achieve better outcomes in radiomics and radiogenomics, future research and development will need to address these issues.…”
Section: Literature Review and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are, however, some studies that did not incorporate validation into their models, such as [ 12 , 16 ]. In addition, studies produced contradictory results that were difficult to compare [ 41 ]. To achieve better outcomes in radiomics and radiogenomics, future research and development will need to address these issues.…”
Section: Literature Review and Discussionmentioning
confidence: 99%
“…Additionally, radiomics measures spatial and temporal intramural heterogeneity non-invasively [ 40 ]. Thus, it is used to extract tumor features inaccessible to the naked eye [ 41 ]. Radiomics has provided significant results by identifying responders and non-responders across various treatment options, including surgery, chemotherapy, immunotherapy, and targeted therapy [ 38 ].…”
Section: Introductionmentioning
confidence: 99%
“…An accurate prediction of cancer survival is very important for counseling, treatment planning, follow-up and postoperative risk assessment in patients with OSCC [ 27 ]. Although the use of prognosis models is still relatively new for OSCC, these models are already widely used for other human diseases [ 28 , 29 , 30 , 31 ]. It is now well known that cancer-related outcomes are influenced by several factors that are not included in the TNM system.…”
Section: Discussionmentioning
confidence: 99%
“…Up to 25% of patients simultaneously experienced primary tumour and colorectal liver metastases (CRLM) diagnosis [ 73 ], while 20% will progress to stage IV. Although the availability of chemotherapy regimen progress in many primary tumours [ 15 ], surgical resection is considered the gold standard treatment for CRLM, with a five-year survival rate from 30% to 60% [ 9 , 40 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 ]. However, about 80% of patients are affected by unresectable CRLM, due to bilobar multiple liver metastases and/or extrahepatic disease.…”
Section: Survivalmentioning
confidence: 99%